Stevanato Group S.p.A. (NYSE:STVN) Given Average Rating of “Moderate Buy” by Analysts

Stevanato Group S.p.A. (NYSE:STVN) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company.

Several equities analysts recently weighed in on STVN shares. Wolfe Research assumed coverage on Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price objective for the company. Bank of America upped their target price on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd.

Hedge Funds Weigh In On Stevanato Group

A number of large investors have recently modified their holdings of STVN. Conestoga Capital Advisors LLC lifted its position in Stevanato Group by 5.5% during the third quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock valued at $153,518,000 after buying an additional 400,087 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in Stevanato Group by 67.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after purchasing an additional 1,123,104 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Stevanato Group by 4.5% during the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after purchasing an additional 115,050 shares in the last quarter. Bamco Inc. NY boosted its position in shares of Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after buying an additional 21,469 shares during the period. Finally, Fred Alger Management LLC lifted its position in shares of Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock worth $21,411,000 after purchasing an additional 208,830 shares in the last quarter.

Stevanato Group Trading Down 4.3 %

NYSE:STVN opened at €22.92 ($23.39) on Tuesday. The stock has a market capitalization of $6.77 billion, a price-to-earnings ratio of 48.77, a PEG ratio of 10.49 and a beta of 0.56. Stevanato Group has a 1 year low of €16.56 ($16.90) and a 1 year high of €34.73 ($35.44). The stock has a fifty day moving average price of €21.24 and a two-hundred day moving average price of €20.23. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.12) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.13) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The company had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. During the same period in the prior year, the firm posted $0.16 EPS. The firm’s quarterly revenue was up 2.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.